What Are Growth Hormone Peptides? | The Gillett Podcast #6

About this video

An early explainer on growth-hormone peptides prompted by public discussion of a prominent podcaster reporting a raised prostate marker while using them. Gillett describes growth hormone as a broad, non-specific signal affecting many tissues, including prostate, fat and connective tissue, and distinguishes two secretagogue families: synthetic versions of growth-hormone-releasing hormone and ghrelin-pathway agonists. He warns that a single IGF-1 result can mislead, because calorie restriction, low insulin signalling and binding-protein levels change interpretation. Gillett argues many users have no true deficiency, that short peri-operative use is a different question from years of continuous use, and that sustained growth signalling raises theoretical cancer concerns he takes seriously.

Key takeaways

• Growth hormone is presented as body-wide and non-selective, not targeted to one tissue
• Secretagogues are unlikely to fix a pituitary-based deficiency, Gillett argues
• IGF-1 should be interpreted with diet, insulin and binding proteins in context
• Sleep and joint anecdotes do not establish deficiency or need
• Years of uninterrupted growth signalling is the pattern that most concerns him

Episode details: published August 10, 2022 · 1.9K views · 9:19 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.

Next: Growth Hormone Peptides, Bear Serum, and Prostate Growth | The Gillett Health Podcast #6 →

All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)